<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">arthyper</journal-id><journal-title-group><journal-title xml:lang="ru">Артериальная гипертензия</journal-title><trans-title-group xml:lang="en"><trans-title>"Arterial’naya Gipertenziya" ("Arterial Hypertension")</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-419X</issn><issn pub-type="epub">2411-8524</issn><publisher><publisher-name>Antihypertensive League</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/1607-419X-2019-25-5-527-539</article-id><article-id custom-type="elpub" pub-id-type="custom">arthyper-1784</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Влияние «белка молодости» GDF11 и «белков старости» CCL11, GDF15, JAM-A на состояние кардиогемодинамических функций у женщин с гипертонической болезнью</article-title><trans-title-group xml:lang="en"><trans-title>The effects of the “youth protein” GDF11 and “aging proteins” ccL11, GDF15, JAM-A on cardiohemodynamics in women with essential hypertension</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2502-9411</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузник</surname><given-names>Б. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuznik</surname><given-names>B. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кузник Борис Ильич — доктор медицинских наук, профессор кафедры нормальной физиологии.</p><p>Ул. Горького, д. 39 А, Чита, 672090, +7(3022)32-16-23</p></bio><bio xml:lang="en"><p>Boris I. Kuznik - MD, PhD, DSc, Professor, Department of Normal Physiology</p><p>39A Gorkii street, Chita, 672090, +7(3022)32-16-23</p></bio><email xlink:type="simple">bi_kuznik@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гусева</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Guseva</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гусева Екатерина Сергеевна — кандидат медицинских наук, заместитель директора по клинико-экспертной и организационно-методической работе.</p><p>Чита</p></bio><bio xml:lang="en"><p>Ekaterina S. Guseva - MD, PhD, Deputy Director for Clinical Expert and Organizational-Methodical Work.</p><p>Chita</p></bio><email xlink:type="simple">guseva81@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Давыдов</surname><given-names>С. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Davydov</surname><given-names>S. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Давыдов Сергей Олегович — доктор медицинских наук, генеральный директор.</p><p>Чита</p></bio><bio xml:lang="en"><p>Sergey O. Davydov - MD, PhD, DSc, General Director.</p><p>Chita</p></bio><email xlink:type="simple">davydov-so@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7920-7642</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смоляков</surname><given-names>Ю. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Smolyakov</surname><given-names>Y. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Смоляков Юрий Николаевич—кандидат медицинских наук, заведующий кафедрой медицинской физики и информатики, SPIN-код: 7440-6632</p></bio><bio xml:lang="en"><p>Yuri N. Smolyakov - MD, PhD, Head, Department of Medical Physics and Informatics</p></bio><email xlink:type="simple">smolyakov@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0975-2351</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цыбиков</surname><given-names>Н. На.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsybikov</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Цыбиков Намжил Нанзатович — доктор медицинских наук, профессор, заведующий кафедрой патологической физиологии</p></bio><bio xml:lang="en"><p>Namzhil N. Tsybikov - MD, PhD, DSc, Professor, Head, Department of Pathological Physiology</p></bio><email xlink:type="simple">thybikov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Читинская государственная медицинская академия» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chita State Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Инновационная клиника Академия здоровья</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Innovative Clinic Health Academy</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>30</day><month>01</month><year>2020</year></pub-date><volume>25</volume><issue>5</issue><fpage>527</fpage><lpage>539</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кузник Б.И., Гусева Е.С., Давыдов С.О., Смоляков Ю.Н., Цыбиков Н.Н., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Кузник Б.И., Гусева Е.С., Давыдов С.О., Смоляков Ю.Н., Цыбиков Н.Н.</copyright-holder><copyright-holder xml:lang="en">Kuznik B.I., Guseva E.S., Davydov S.O., Smolyakov Y.N., Tsybikov N.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://htn.almazovcentre.ru/jour/article/view/1784">https://htn.almazovcentre.ru/jour/article/view/1784</self-uri><abstract><p>Цель исследования — выявить, как влияют белки «молодости и старости» — GDF11, CCL11, GDF15, JAM-A — на состояние кардиогемодинамических функций у здоровых и больных эссенциальной гипертензией женщин.</p><sec><title>Материалы и методы</title><p>Материалы и методы. В исследовании приняли участие 102 женщины. Контрольную группу составили 30 относительно здоровых женщин. Больные гипертонической болезнью (ГБ) были разделены на 2 группы: в первую (ГБ-1) вошли 37 женщин с артериальной гипертензией II стадии, получавшие антигипертензивную терапию, во вторую (ГБ-2) — 35 пациенток, наряду с антигипертензивными препаратами регулярно на протяжении 2-3 лет проходившие курсы кинезитерапии. У всех испытуемых методом иммуноферментного анализа (ИФА) определялось содержание белков GDF11, GDF15, JAM-A и CCL11. Состояние сердечно-сосудистой системы оценивали с помощью эхокардиографии и динамического рассеяния света (Dynamic Light Scattering — DLS).</p></sec><sec><title>Результаты</title><p>Результаты. У здоровых женщин установлены прямые взаимосвязи между белками GDF15 и JAM-A и уровнем артериального давления (АД). Соотношение GDF11/GDF15 обратно коррелирует с показателями АД. У больных ГБ-1 выявлена отрицательная связь между концентрацией белка GDF15 и уровнем систолического среднего и пульсового давления. В группе ГБ-2 установлена отрицательная связь между белком CCL11 и пульсовым давлением, а также соотношением GDF15/CCL11 и величиной диастолического АД и положительная — с величиной пульсового давления. У здоровых людей не выявлено существенных взаимосвязей между исследуемыми белками и кардиодинамическими функциями, но зарегистрированы положительные взаимосвязи между соотношением GDF11/CCL11 и эхокардиографическими показателями: конечным систолическим и ударным объемами. В группе ГБ-2 выявлена положительная взаимосвязь между соотношением GDF11/GDF15 и минутным объемом, а также GDF15/CCL11 и систолическим укорочением. Абсолютные значения гемодинамических индексов (Hemodynamic Index — HI) у женщин ГБ-1 были ниже, чем в контрольной группе, что свидетельствует о нарушении микроциркуляторной динамики. Баланс распределения скоростей в артериях и микроциркуляторном русле у женщин группы ГБ-1 изменяется в сторону быстрых сдвигов. У женщин группы ГБ-2 показатели гемодинамики были в значительной степени близки к контрольной группе. Как у здоровых, так и у больных ГБ-1 и ГБ-2 обнаружены многочисленные связи между исследуемыми белками, их соотношениями и различными гемодинамическими и осцилляторными индексами.</p></sec><sec><title>Заключение</title><p>Заключение. Концентрации «белка молодости» GDF11 и «белков старости» GDF15, CCL11, JAM-A, а также их соотношения проявляют многогранные положительные и отрицательные взаимосвязи с уровнем АД и кардиогемодинамическими функциями. При этом действие GDF11 и его преобладание над CCL11, GDF15 и JAM-A носит преимущественно приспособительный характер.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective. To identify the effects of youth and aging proteins — GDF11, CCL11, GDF15, JAM-A on cardiohemodynamics in healthy and hypertensive women.</p></sec><sec><title>Design and methods</title><p>Design and methods. The study involved 102 women. The control group consisted of 30 healthy women. Hypertensives were divided into 2 groups. The first (HTN-1) included 37 women with stage II hypertension (HTN) who received antihypertensive therapy. The second group (HTN-2) included patients who received antihypertensive drugs and regularly underwent kinesitherapy for 2-3 years. The enzyme immunoassay (ELISA) method was performed to determine the levels of GDF11, GDF15, JAM-A and CCL11 proteins. All subjects underwent echocardiography and dynamic light scattering (DLS).</p></sec><sec><title>Results</title><p>Results. In healthy women, we found a positive correlation between the GDF15 proteins and JAM-A and blood pressure (BP). The GDF11/GDF15 ratio negatively correlated with BP level. In HTN-1 group, a negative relationship was found between the GDF15 level and the mean and pulse systolic pressure. In HTN-2 group, a negative relationship was found between CCL11 protein and pulse pressure, as well as the GDF15/CCL11 ratio and diastolic and positive correlation with the pulse pressure. In healthy subjects, no significant correlations were found between the studied proteins and cardiovascular functions, but GDF11/CCL11 ratio positively correlated with echocardiographic indices: the final systolic and impact volumes. In HTN-2 group, a positive relationship was found between the GDF11/GDF15 ratio and the minute volume, as well as GDF15/CCL11 and systolic shortening. The absolute values of hemodynamic indices (HI) in HTN-1 group were lower than in the control group, indicating a violation of the microcirculation with the trend towards the higher velocities. In HTN-2 group, hemodynamic parameters were close to those in the control group. In healthy individuals, HTN-1 and HTN-2 groups, dozens correlations were found between the studied proteins, their ratios, and various hemodynamic and oscillatory indices.</p></sec><sec><title>Conclusions</title><p>Conclusions. The levels of the “youth protein” GDF11 and the “aging proteins” GDF15, CCL11, JAM-A, as well as their ratios, exhibit positive and negative relationships with BP and cardiohemodynamic functions. At the same time, the effect of GDF11 and its predominance over CCL11, GDF15 and JAM-A is mostly adaptive.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>GDF11</kwd><kwd>GDF15</kwd><kwd>CCL11</kwd><kwd>JAMA</kwd><kwd>гипертоническая болезнь</kwd><kwd>артериальное давление</kwd><kwd>кардио- и гемодинамика</kwd><kwd>гемодинамические индексы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>GDF11</kwd><kwd>GDF15</kwd><kwd>CCL11</kwd><kwd>JAM-A</kwd><kwd>hypertension</kwd><kwd>blood pressure</kwd><kwd>cardiodynamics</kwd><kwd>hemodynamics</kwd><kwd>hemodynamic indices</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Loffredo FS, Steinhauser ML, Jay SM, Gannon J, Pancoast JR, Yalamanchi P et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 2013; 153(4):828-839. doi:10.1016/j.cell.2013.04.015</mixed-citation><mixed-citation xml:lang="en">Loffredo FS, Steinhauser ML, Jay SM, Gannon J, Pancoast JR, Yalamanchi P et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 2013; 153(4):828-839. doi:10.1016/j.cell.2013.04.015</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Castellano JM. Blood-based therapies to combat aging. Gerontology. 2019;65(1):84-89. doi:10.1159/000492573</mixed-citation><mixed-citation xml:lang="en">Castellano JM. Blood-based therapies to combat aging. Gerontology. 2019;65(1):84-89. doi:10.1159/000492573</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Кузник Б. И., Давыдов С. О., Степанов А. В., Смоляков Ю. Н., Гусева Е. С. Значение «белка молодости» — GDF11 и «белков старости» — GDF15, CCL11, JAM-A в регуляции кровяного давления у здоровых и страдающих гипертонической болезнью женщин. Патол. физиол и экспер. терап. 2018;2:46-52. doi: 10.25557/0031-2991.2018.02.46-52</mixed-citation><mixed-citation xml:lang="en">Kuznik BI, Davydov SO, Stepanov AV, Smolyakov YN, Guseva ES. The value of “youth protein” — GDF11 and “proteins of old age” — GDF15, CCL11, JAM-A in the regulation of blood pressure in healthy and hypertensive women. Patologi-cheskaya Fiziologiya i Eksperimental’naya Terapiya = Pathological Physiology and Experimental Therapy. 2018;2:46-52. doi:10.25557/0031-2991.2018.02.46-52. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Кузник Б. И., Хавинсон В. Х., Давыдов С. О., Степанов А. В. Белки молодости и старости. Белки — маркеры клеточного старения и предсказатели продолжительности жизни. Palmarium, academic publishing. 2017. 285 с.</mixed-citation><mixed-citation xml:lang="en">Kuznik BI, Khavinson VKh, Davydov SO, Stepanov AV. The proteins of youth and old age. The proteins are the markers of cellular aging and predictors of life expectancy. Palmarium, academic publishing. 2017. 285 p. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Khavinson VKh, Kuznik BI, Tarnovskaya SI, Linkova NS. GDF11 Protein as a Geroprotector. Biology Bulletin Reviews. 2016;6(2):141-148. doi:10.1134/S207908641602002X</mixed-citation><mixed-citation xml:lang="en">Khavinson VKh, Kuznik BI, Tarnovskaya SI, Linkova NS. GDF11 Protein as a Geroprotector. Biology Bulletin Reviews. 2016;6(2):141-148. doi:10.1134/S207908641602002X</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tito A, Barbulova A, Zappelli C, Leone M, Ruvo M, Mercu-rio FA et al. The growth differentiation factor 11 is involved in skin fibroblast ageing and is induced by a preparation of peptides and sugars derived from plant cell cultures. Mol Biotechnol. 2019;61 (3):209-220. doi:10.1007/s12033-019-00154-w</mixed-citation><mixed-citation xml:lang="en">Tito A, Barbulova A, Zappelli C, Leone M, Ruvo M, Mercu-rio FA et al. The growth differentiation factor 11 is involved in skin fibroblast ageing and is induced by a preparation of peptides and sugars derived from plant cell cultures. Mol Biotechnol. 2019;61 (3):209-220. doi:10.1007/s12033-019-00154-w</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang C, Wang Y, Ge Z, Lin J, Liu J, Yuan X et al. GDF11 attenuated ANG II-induced hypertrophic cardiomyopathy and expression of ANP, BNP and beta-MHC through downregulating CCL11 in mice. Curr Mol Med. 2018;18(10):661-671. doi:10.2174/1566524019666190204112753</mixed-citation><mixed-citation xml:lang="en">Zhang C, Wang Y, Ge Z, Lin J, Liu J, Yuan X et al. GDF11 attenuated ANG II-induced hypertrophic cardiomyopathy and expression of ANP, BNP and beta-MHC through downregulating CCL11 in mice. Curr Mol Med. 2018;18(10):661-671. doi:10.2174/1566524019666190204112753</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Кузник Б. И., Давыдов С. О., Гусева Е. С., Степанов А. В., Смоляков Ю. Н., Цыбиков Н. Н. и др. Взаимоотношение отдельных популяций лейкоцитов и деятельность сердечнососудистой системы у женщин, страдающих гипертонической болезнью. Системные гипертензии. 2017;14(4):32-37. doi:10.26442/2075-082X_14.4.32-37</mixed-citation><mixed-citation xml:lang="en">Kuznik BI, Davydov SO, Guseva ES, Stepanov AV, Smolyakov YN, Tsybikov NN et al. The relationship of individual leukocyte populations and the activity of the cardiovascular system in women suffering from hypertension. Sistemnye Gipertenzii = Systemic Hypertension. 2017;14(4):32-37. doi:10.26442/2075-082X_14.4.32-37. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Кузник Б. И., Давыдов С. О., Степанов А. В., Гусева Е. С., Смоляков Ю. Н., Файн И. В. Адгезивная молекула JAM-A и патогенетические механизмы формирования гипертонической болезни. Артериальная гипертензия. 2018:24(3):293-302. doi:10.18705/1607-419X-2018-24-3-293-302</mixed-citation><mixed-citation xml:lang="en">Kuznik BI, Davydov SO, Stepanov AV, Guseva ES, Smolyakov YN, Fayn IV. Adhesive JAM-A molecule and pathogenetic mechanisms of hypertension formation. Arterial’naya Gipertenziya = Arterial Hypertension. 2018:24(3):293-302. doi:10.18705/1607-419X-2018-24-3-293-302. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011;477(7362):90-94. doi:10.1038/nature10357</mixed-citation><mixed-citation xml:lang="en">Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011;477(7362):90-94. doi:10.1038/nature10357</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lalli MA, Bettcher BM, Arcila ML. Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer’s disease. Mol Psychiatry. 2015;20 (11):1294-1300. doi:10.1038/mp.2015.131</mixed-citation><mixed-citation xml:lang="en">Lalli MA, Bettcher BM, Arcila ML. Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer’s disease. Mol Psychiatry. 2015;20 (11):1294-1300. doi:10.1038/mp.2015.131</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Stuart MJ, Singhal G, Baune BT. Systematic review of the neurobiological relevance of chemokines to psychiatric disorders. Front Cell Neurosci. 2015;9:357. doi:10.3389/fncel.2015.00357</mixed-citation><mixed-citation xml:lang="en">Stuart MJ, Singhal G, Baune BT. Systematic review of the neurobiological relevance of chemokines to psychiatric disorders. Front Cell Neurosci. 2015;9:357. doi:10.3389/fncel.2015.00357</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Emanuele E, Falcone C, D’Angelo A, Minoretti P, Buzzi MP, Bertona M et al. Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease. Atherosclerosis. 2006;186(1):140-145. doi:10.1016/j.atherosclerosis. 2005.07.002</mixed-citation><mixed-citation xml:lang="en">Emanuele E, Falcone C, D’Angelo A, Minoretti P, Buzzi MP, Bertona M et al. Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease. Atherosclerosis. 2006;186(1):140-145. doi:10.1016/j.atherosclerosis. 2005.07.002</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Wiklund FE, Bennet AM, Magnusson PK, Eriksson UK, Lindmark F, Wu L et al. Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality. Aging Cell. 2010;9(6):1057-1064. doi:10.1111/j.1474-9726.2010.00629.x</mixed-citation><mixed-citation xml:lang="en">Wiklund FE, Bennet AM, Magnusson PK, Eriksson UK, Lindmark F, Wu L et al. Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality. Aging Cell. 2010;9(6):1057-1064. doi:10.1111/j.1474-9726.2010.00629.x</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Daniels LB, Clopton P, Laughlin GA, Maisel AS, Barrett-Connor E. Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: The Rancho Bernardo Study. Circulation. 2 011;123 (19):2101—2110. doi:10.1161/CIRCULATIONAHA.n0.979740</mixed-citation><mixed-citation xml:lang="en">Daniels LB, Clopton P, Laughlin GA, Maisel AS, Barrett-Connor E. Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: The Rancho Bernardo Study. Circulation. 2 011;123 (19):2101—2110. doi:10.1161/CIRCULATIONAHA.n0.979740</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Maetzler W, Deleersnijder W, Hanssens V, Bernard A, Brockmann K, Marquetand J et al. GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia. PLoS One. 2016;11(3):e0149349. doi:10.1371/journal.pone.0149349</mixed-citation><mixed-citation xml:lang="en">Maetzler W, Deleersnijder W, Hanssens V, Bernard A, Brockmann K, Marquetand J et al. GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia. PLoS One. 2016;11(3):e0149349. doi:10.1371/journal.pone.0149349</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang J, Wen W, Sachdev PS. Macrophage inhibitory cytokine-1/growth differentiation factor 15 as a marker of cognitive ageing and dementia. Curr Opin Psychiatry. 2016;29(2):181—186. doi:10.1097/YC0.0000000000000225</mixed-citation><mixed-citation xml:lang="en">Jiang J, Wen W, Sachdev PS. Macrophage inhibitory cytokine-1/growth differentiation factor 15 as a marker of cognitive ageing and dementia. Curr Opin Psychiatry. 2016;29(2):181—186. doi:10.1097/YC0.0000000000000225</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Berezin AE. Diabetes mellitus related biomarker: the predictive role of growth-differentiation factor-15. Diabetes Metab Syndr. 2016;10(1Suppl1):S154-S157. doi.org/10.1016/j.dsx.2015.09.016</mixed-citation><mixed-citation xml:lang="en">Berezin AE. Diabetes mellitus related biomarker: the predictive role of growth-differentiation factor-15. Diabetes Metab Syndr. 2016;10(1Suppl1):S154-S157. doi.org/10.1016/j.dsx.2015.09.016</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Bonaterra GA, Zugel S, Thogersen J, Walter SA, Haberkorn U, Strelau J et al. Growth differentiation factor-15 deficiency inhibits atherosclerosis progression by regulating interleukin-6-dependent i nflammatory response to vascular injury. JAm HeartAssoc. 2012;1 (6):1—14. doi.org/10.1161/JAHA.112.002550</mixed-citation><mixed-citation xml:lang="en">Bonaterra GA, Zugel S, Thogersen J, Walter SA, Haberkorn U, Strelau J et al. Growth differentiation factor-15 deficiency inhibits atherosclerosis progression by regulating interleukin-6-dependent i nflammatory response to vascular injury. JAm HeartAssoc. 2012;1 (6):1—14. doi.org/10.1161/JAHA.112.002550</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Xu H, Oliveira-Sales EB, McBride F, Liu B, Hewinson J, Toward M et al. Upregulation ofjunctional adhesion molecule-A is a putative prognostic marker of hypertension. Cardiovasc Res. 2012;96(3):552-560. doi:10.1093/cvr/cvs273</mixed-citation><mixed-citation xml:lang="en">Xu H, Oliveira-Sales EB, McBride F, Liu B, Hewinson J, Toward M et al. Upregulation ofjunctional adhesion molecule-A is a putative prognostic marker of hypertension. Cardiovasc Res. 2012;96(3):552-560. doi:10.1093/cvr/cvs273</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Давыдов С. О., Степанов А. В., Кузник Б. И., Гусева Е. С. Влияние кинезитерапии на уровень адгезивной молекулы jam-a у больных гипертонической болезнью. Вестник восстановительной медицины. 2017;5:33-37.</mixed-citation><mixed-citation xml:lang="en">Davydov SO, Stepanov AV, Kuznik BI, Guseva ES. The effect of kinesitherapy on the level of the jam-a adhesive molecule in patients with essential hypertension. Vestnik Vosstanovitel’noj Meditsiny = Bulletin of Restorative Medicine. 2017;5:33-37. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Гусева Е. С., Давыдов С. О., Кузник Б. И., Смоляков Ю. Н., Степанов А. В., Файн И. В. и др. Роль дифференци-ровочного фактора роста 11 (GDF11) в регуляции липидного обмена и кардиогемодинамических функций у больных гипертонической болезнью при умеренной физической нагрузке. Российский кардиологический журнал. 2018;4:93-98. doi:10.15829/1560-4071-2018-4-93-98</mixed-citation><mixed-citation xml:lang="en">Guseva ES, Davydov SO, Kuznik BI, Smolyakov YN, Stepanov AV, Fayn IV et al. The role of differentiation growth factor 11 (GDF11) in the regulation of lipid metabolism and cardiohemodynamic functions in patients with essential hypertension and moderate exercise. Rossijskij Kardiologicheskij Zhurnal = Russian Journal of Cardiology. 2018;4:93-98. doi: 10.15829/1560-4071-2018-4-93-98. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Кузник Б. И., Давыдов С. О., Смоляков Ю. Н., Степанов А. В., Гусева Е. С., Файн И. В. и др. Роль белков «молодости и старости» в патогенезе гипертонической болезни. Успехи геронтологии. 2018;31(3):362-367.</mixed-citation><mixed-citation xml:lang="en">Kuznik BI, Davydov SO, Smolyakov YN, Stepanov AV, Guseva ES, Fain IV et al. The role of proteins “youth and old age” in the pathogenesis of hypertension. Successes of Gerontology. 2018;31(3):362-367. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Кузник Б. И., Давыдов С. О., Ройтман Е. В., Смоляков Ю. Н., Гусева Е. С., Степанов А. С. и др. Белок GDF15 и состояние кардиогемодинамических функций у женщин с гипертонической болезнью. Врач. 2019;30(1):3-9. doi:10.29296/25877305-2019-01-01</mixed-citation><mixed-citation xml:lang="en">Kuznik BI, Davydov SO, Roytman EV, Smolyakov YN, Guseva ES, Stepanov AS et al. Protein GDF15 and the state of cardiohemodynamic functions in women with hypertension. Vrach = Doctor. 2019;30(1):3-9. doi:10.29296/25877305-2019-01-01. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ahn ST, Suh SI, Moon H, Hyun C. Evaluation of growth differentiation factor 11 (GDF11) levels in dogs with chronic mitral valve insufficiency. Can J Vet Res. 2016;80(1):90-92.</mixed-citation><mixed-citation xml:lang="en">Ahn ST, Suh SI, Moon H, Hyun C. Evaluation of growth differentiation factor 11 (GDF11) levels in dogs with chronic mitral valve insufficiency. Can J Vet Res. 2016;80(1):90-92.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Roy-O’Reilly M, Ritzel RM, Conway SE, Staff I, Fortunato G, McCullough LD. CCL11 (Eotaxin-1) levels predict long-term functional outcomes in patients following ischemic stroke. Transl Stroke Res. 2017;8(6):578-84. doi:10.1007/s12975-017-0545-3</mixed-citation><mixed-citation xml:lang="en">Roy-O’Reilly M, Ritzel RM, Conway SE, Staff I, Fortunato G, McCullough LD. CCL11 (Eotaxin-1) levels predict long-term functional outcomes in patients following ischemic stroke. Transl Stroke Res. 2017;8(6):578-84. doi:10.1007/s12975-017-0545-3</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Johnen H, Kuffner T, Brown DA, Wu BJ, Stocker R, Breit SN. Increased expression of the TGF-b superfamily cytokine MIC-1/GDF15 protects ApoE (-/-) mice from the development of atherosclerosis. Cardiovascular Pathology. 2012;21(6):499-505. doi:10.1016/j.carpath.2012.02.003</mixed-citation><mixed-citation xml:lang="en">Johnen H, Kuffner T, Brown DA, Wu BJ, Stocker R, Breit SN. Increased expression of the TGF-b superfamily cytokine MIC-1/GDF15 protects ApoE (-/-) mice from the development of atherosclerosis. Cardiovascular Pathology. 2012;21(6):499-505. doi:10.1016/j.carpath.2012.02.003</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Fine I, Kuznik B, Kaminsky A et al. New noninvasive index for evaluation of the vascular age of healthy and sick people. J Biomed Opt. 2012;17(8):087002-1. doi:10.1117/1.JBO.17.8.087002</mixed-citation><mixed-citation xml:lang="en">Fine I, Kuznik B, Kaminsky A et al. New noninvasive index for evaluation of the vascular age of healthy and sick people. J Biomed Opt. 2012;17(8):087002-1. doi:10.1117/1.JBO.17.8.087002</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Fine I, Kaminsky AV, Kuznik BI, Kustovsjya EM, Maximova OG, Shenkman L. A new sensor for stress measurement based on blood flow fluctuations. Dynamics and Fluctuations in Biomedical Photonics XII, edited by Valery V. Tuchin. SPIE Press. 2016;9707:970705. doi:10.1117/12.2212866</mixed-citation><mixed-citation xml:lang="en">Fine I, Kaminsky AV, Kuznik BI, Kustovsjya EM, Maximova OG, Shenkman L. A new sensor for stress measurement based on blood flow fluctuations. Dynamics and Fluctuations in Biomedical Photonics XII, edited by Valery V. Tuchin. SPIE Press. 2016;9707:970705. doi:10.1117/12.2212866</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2018. [Electronic resource] Available at: https://www.R-project.org (Accessed 23 January 2019).</mixed-citation><mixed-citation xml:lang="en">R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2018. [Electronic resource] Available at: https://www.R-project.org (Accessed 23 January 2019).</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Кузник Б. И., Линькова Н. С., Колчина Н. В., Кукано-ва Е. О., Хавинсон В. Х. Семейство молекул JAM и их роль в регуляции физиологических и патологических процессов. Успехи физиологических наук. 2016;47(4):76-98.</mixed-citation><mixed-citation xml:lang="en">Kuznik BI, Linkova NS, Kolchina NV, Kukаnova EO, Khavinson VKh. The family of JAM molecules and their role in the regulation of physiological and pathological processes. Uspekhi Fiziologicheskih Nauk = Successes Fiziol. Sciences. 2016;47(4):76-98. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Ong KL, Leung RY, Babinska A, Salifu MO, Ehrlich YH, Kornecki E et al. Elevated plasma level of soluble F11 receptor/ junctional adhesion molecule-A (F11R/JAM-A) in hypertension. Am J Hypertens. 2009;22(5):500-505.doiorg/10.1038/ajh.2009.23</mixed-citation><mixed-citation xml:lang="en">Ong KL, Leung RY, Babinska A, Salifu MO, Ehrlich YH, Kornecki E et al. Elevated plasma level of soluble F11 receptor/ junctional adhesion molecule-A (F11R/JAM-A) in hypertension. Am J Hypertens. 2009;22(5):500-505.doiorg/10.1038/ajh.2009.23</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Schmitt MM, Fraemohs L, Hackeng TM, Weber C, Koenen RR. Atherogenic mononuclear cell recruitment is facilitated by oxidized lipoprotein-induced endothelial junctional adhesion molecule-A redistribution. Atherosclerosis. 2014;234(2):254-264. doi:10.1016/j.atherosclerosis.2014.03.014</mixed-citation><mixed-citation xml:lang="en">Schmitt MM, Fraemohs L, Hackeng TM, Weber C, Koenen RR. Atherogenic mononuclear cell recruitment is facilitated by oxidized lipoprotein-induced endothelial junctional adhesion molecule-A redistribution. Atherosclerosis. 2014;234(2):254-264. doi:10.1016/j.atherosclerosis.2014.03.014</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Julien C. The enigma of Mayer waves: facts and models. Cardiovascular Research. 2006;(70)1:12-21. doi:10.1016/j.cardiores.2005.11.008</mixed-citation><mixed-citation xml:lang="en">Julien C. The enigma of Mayer waves: facts and models. Cardiovascular Research. 2006;(70)1:12-21. doi:10.1016/j.cardiores.2005.11.008</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Хавинсон В. Х., Кузник Б. И., Рыжак Г. А., Линькова Н. С., Козина Л. С., Салль Т. С. «Белок старости» CCl11, «белок молодости» GDF11 и их роль в возрастной патологии. Успехи геронтологии. 2016;29(5):722-31.</mixed-citation><mixed-citation xml:lang="en">Khavinson VKh, Kuznik BI, Ryzhak GA, Linkova NS, Kozina LS, Sall TS. “Protein of old age” CCl11, “protein of youth” GDF11 and their role in age-related pathology. Uspekhi Gerontologii = Successes of Gerontology. 2016; 29(5):722-731. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Schmitt MM, Megens RT, Zernecke A, Bidzhekov K, van den Akker NM, Rademakers T et al. Endothelial junctional adhesion molecule-a guides monocytes into flow-dependent predilection sites of atherosclerosis. Circulation. 2014;129(1):66-76. doi:10. 1161/CIRCULATIONAHA.113.004149</mixed-citation><mixed-citation xml:lang="en">Schmitt MM, Megens RT, Zernecke A, Bidzhekov K, van den Akker NM, Rademakers T et al. Endothelial junctional adhesion molecule-a guides monocytes into flow-dependent predilection sites of atherosclerosis. Circulation. 2014;129(1):66-76. doi:10. 1161/CIRCULATIONAHA.113.004149</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Khavinson VKh, Kuznik BI, Tarnovskaya SI, Linkova NS. Peptides and CCL11 and HMGB1 as molecular markers of aging: literature review and own data. Adv Gerontol. 2015;5(3):133-140. doi:10.1134/S2079057015030078</mixed-citation><mixed-citation xml:lang="en">Khavinson VKh, Kuznik BI, Tarnovskaya SI, Linkova NS. Peptides and CCL11 and HMGB1 as molecular markers of aging: literature review and own data. Adv Gerontol. 2015;5(3):133-140. doi:10.1134/S2079057015030078</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Cho SY, Roh HT. Effects of aerobic exercise training on peripheral brain-derived neurotrophic factor and eotaxin-1 levels in obese young men. J Phys Ther Sci. 2016;28(4):1355-1358.</mixed-citation><mixed-citation xml:lang="en">Cho SY, Roh HT. Effects of aerobic exercise training on peripheral brain-derived neurotrophic factor and eotaxin-1 levels in obese young men. J Phys Ther Sci. 2016;28(4):1355-1358.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Brack AS. Ageing of the heart reversed by youthful systemic factors! EMBO J. 2013;32(16):2189-2190. doi:10.1038/emboj.2013.162</mixed-citation><mixed-citation xml:lang="en">Brack AS. Ageing of the heart reversed by youthful systemic factors! EMBO J. 2013;32(16):2189-2190. doi:10.1038/emboj.2013.162</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Wang X, Yang X, Sun K, Chen J, Song X, Wang H et al. The haplotype of the growth-differentiation factor 15 gene is associated with left ventricular hypertrophy in human essential hypertension. Clin Sci. 2009;118(2):137-145. doi: 10.1042/CS20080637</mixed-citation><mixed-citation xml:lang="en">Wang X, Yang X, Sun K, Chen J, Song X, Wang H et al. The haplotype of the growth-differentiation factor 15 gene is associated with left ventricular hypertrophy in human essential hypertension. Clin Sci. 2009;118(2):137-145. doi: 10.1042/CS20080637</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Ушаков А. В., Иванченко В. С., Гагарина А. А. Особенности профиля артериального давления и вариабельности сердечного ритма у больных артериальной гипертензией в зависимости от уровня физической активности и психоэмоционального напряжения. Российский кардиологический журнал. 2017;4:23-28. doi:10.15829/1560-4071-2017-4-2 3-28</mixed-citation><mixed-citation xml:lang="en">Ushakov AV, Ivanchenko VS, Gagarina AA. Features of blood pressure profile and heart rate variability in patients with arterial hypertension, depending on the level of physical activity and psycho-emotional stress. Rossijskij Kardiologicheskij Zhurnal = Russian Journal of Cardiology. 2017;4:23-28. doi:10.15829/1560-4071-2017-4-23-28 In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Ройтман Е. В. Клиническая гемореология. Тромбоз, гемостаз и реология. 2003;3:13-27.</mixed-citation><mixed-citation xml:lang="en">Roitman E. V. Clinical hemorheology. Tromboz, Gemostaz i Reologiya = Thrombosis, Hemostasis and Rheology. 2003;3:13-27. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Prestgaard E, Mariampillai J, Engeseth K, Erikssen J, Bodegard J, Liest0l K et al. Change in cardiorespiratory fitness and risk of stroke and death. Stroke. 2019;50(1):155-161. doi:10.1161/STROKEAHA.118.021798</mixed-citation><mixed-citation xml:lang="en">Prestgaard E, Mariampillai J, Engeseth K, Erikssen J, Bodegard J, Liest0l K et al. Change in cardiorespiratory fitness and risk of stroke and death. Stroke. 2019;50(1):155-161. doi:10.1161/STROKEAHA.118.021798</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
